Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 1
1990 1
1995 1
1996 1
1998 2
1999 2
2000 1
2001 1
2004 1
2005 1
2006 2
2007 2
2009 2
2010 6
2011 3
2012 5
2013 3
2014 12
2015 9
2016 7
2017 7
2018 9
2019 11
2020 7
2021 6
2022 8
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20HL, 5BAuthor
Page 1
Timing of Prone Positioning During Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome.
Giani M, Rezoagli E, Guervilly C, Rilinger J, Duburcq T, Petit M, Textoris L, Garcia B, Wengenmayer T, Bellani G, Grasselli G, Pesenti A, Combes A, Foti G, Schmidt M; European Prone positioning During Extracorporeal Membrane Oxygenation (EuroPronECMO) Investigators. Giani M, et al. Crit Care Med. 2023 Jan 1;51(1):25-35. doi: 10.1097/CCM.0000000000005705. Epub 2022 Nov 9. Crit Care Med. 2023. PMID: 36519981
A review of the psychometric properties of generic utility measures in multiple sclerosis.
Kuspinar A, Mayo NE. Kuspinar A, et al. Pharmacoeconomics. 2014 Aug;32(8):759-73. doi: 10.1007/s40273-014-0167-5. Pharmacoeconomics. 2014. PMID: 24846760 Review.
RESULTS: The following generic utility measures were identified: the EQ-5D (n = 9)/EQ-5D-5 Level (EQ-5D-5L) (n = 1), followed by the Health Utilities Index Mark 3/2 (HUI2/HUI3) (n = 3), the SF-6D (n = 2), the Assessment of Quality of Life (AQOL) (n = 2), and …
RESULTS: The following generic utility measures were identified: the EQ-5D (n = 9)/EQ-5D-5 Level (EQ-5D-5L) (n = 1), fo …
Impaired health-related quality of life in long-COVID syndrome after mild to moderate COVID-19.
Malesevic S, Sievi NA, Baumgartner P, Roser K, Sommer G, Schmidt D, Vallelian F, Jelcic I, Clarenbach CF, Kohler M. Malesevic S, et al. Sci Rep. 2023 May 12;13(1):7717. doi: 10.1038/s41598-023-34678-8. Sci Rep. 2023. PMID: 37173355 Free PMC article.
Patients who received an alternative diagnosis or suffered from a severe acute Covid-19 infection were excluded. St. George's Respiratory Questionnaire (SGRQ), Euroquol-5D-5L (EQ-5D-5L), and the Short form 36 (SF-36) were distributed to assess HRQoL. 112 patients we …
Patients who received an alternative diagnosis or suffered from a severe acute Covid-19 infection were excluded. St. George's Respiratory Qu …
Cerebellar Volume and Disease Staging in Parkinson's Disease: An ENIGMA-PD Study.
Kerestes R, Laansma MA, Owens-Walton C, Perry A, van Heese EM, Al-Bachari S, Anderson TJ, Assogna F, Aventurato ÍK, van Balkom TD, Berendse HW, van den Berg KRE, Betts R, Brioschi R, Carr J, Cendes F, Clark LR, Dalrymple-Alford JC, Dirkx MF, Druzgal J, Durrant H, Emsley HCA, Garraux G, Haroon HA, Helmich RC, van den Heuvel OA, João RB, Johansson ME, Khachatryan SG, Lochner C, McMillan CT, Melzer TR, Mosley PE, Newman B, Opriessnig P, Parkes LM, Pellicano C, Piras F, Pitcher TL, Poston KL, Rango M, Roos A, Rummel C, Schmidt R, Schwingenschuh P, Silva LS, Smith V, Squarcina L, Stein DJ, Tavadyan Z, Tsai CC, Vecchio D, Vriend C, Wang JJ, Wiest R, Yasuda CL, Young CB, Jahanshad N, Thompson PM, van der Werf YD, Harding IH; ENIGMA-Parkinson's Study. Kerestes R, et al. Mov Disord. 2023 Dec;38(12):2269-2281. doi: 10.1002/mds.29611. Epub 2023 Nov 14. Mov Disord. 2023. PMID: 37964373 Free article.
Dose-response relationships of LSD-induced subjective experiences in humans.
Hirschfeld T, Prugger J, Majić T, Schmidt TT. Hirschfeld T, et al. Neuropsychopharmacology. 2023 Oct;48(11):1602-1611. doi: 10.1038/s41386-023-01588-2. Epub 2023 May 9. Neuropsychopharmacology. 2023. PMID: 37161078 Free PMC article.
The psychometric data comprised ratings of subjective effects from standardized and validated questionnaires: the Altered States of Consciousness Rating Scale (5D-ASC, 11-ASC) and the Mystical Experience Questionnaire (MEQ30). ...
The psychometric data comprised ratings of subjective effects from standardized and validated questionnaires: the Altered States of Consciou …
Stroke survivors' preferences on assessing patient-reported outcome measures.
Schmidt R, Geisler D, Urban D, Pries R, Franzisket C, Voigt C, Ivanova G, Neumuth T, Classen J, Wagner M, Michalski D. Schmidt R, et al. J Patient Rep Outcomes. 2023 Nov 30;7(1):124. doi: 10.1186/s41687-023-00660-1. J Patient Rep Outcomes. 2023. PMID: 38032486 Free PMC article.
METHODS: A paper-based questionnaire was sent to stroke survivors treated at the Department of Neurology, University of Leipzig, Germany. Health-related quality of life (HRQoL, EQ-5D-5L) and preferences regarding different aspects of data collection to assess PROMs were in …
METHODS: A paper-based questionnaire was sent to stroke survivors treated at the Department of Neurology, University of Leipzig, Germany. He …
Trial Participation and Outcomes Among English-Speaking and Spanish-Speaking Patients With Appendicitis Randomized to Antibiotics: A Secondary Analysis of the CODA Randomized Clinical Trial.
Serrano E, Voldal EC, Machado-Aranda D, DeUgarte DA, Kao L, Drake T, Winchell R, Cuschieri J, Krishnadasan A, Talan DA, Siparsky N, Ayoung-Chee P, Self WH, McGonagill P, Mandell KA, Liang MK, Dodwad SJ, Thompson CM, Padilla RM, Fleischman R, Price TP, Jones A, Bernardi K, Garcia L, Evans HL, Sanchez SE, Odom S, Comstock BA, Heagerty PJ, Lawrence SO, Monsell SE, Fannon EEC, Kessler LG, Flum DR, Davidson GH; Writing Group for the CODA Collaborative. Serrano E, et al. JAMA Surg. 2023 Sep 1;158(9):901-908. doi: 10.1001/jamasurg.2023.2277. JAMA Surg. 2023. PMID: 37379001
MAIN OUTCOMES AND MEASURES: Trial participation, European Quality of Life-5 Dimensions (EQ-5D) questionnaire scores (higher scores indicating a better health status), rate of appendectomy, treatment satisfaction, decisional regret, and days of work missed. ...Among Spanish …
MAIN OUTCOMES AND MEASURES: Trial participation, European Quality of Life-5 Dimensions (EQ-5D) questionnaire scores (higher scores in …
Prehabilitation in older patients prior to elective cardiac procedures (PRECOVERY): study protocol of a multicenter randomized controlled trial.
Steinmetz C, Heinemann S, Kutschka I, Hasenfuß G, Asendorf T, Remppis BA, Knoglinger E, Grefe C, Albes JM, Baraki H, Baumbach C, Brunner S, Ernst S, Harringer W, Heider D, Heidkamp D, Herrmann-Lingen C, Hummers E, Kocar T, König HH, Krieger S, Liebold A, Martens A, Matzeder M, Mellert F, Müller C, Puls M, Reiss N, Schikora M, Schmidt T, Vestweber M, Sadlonova M, von Arnim CAF; PRECOVERY investigators. Steinmetz C, et al. Trials. 2023 Aug 15;24(1):533. doi: 10.1186/s13063-023-07511-w. Trials. 2023. PMID: 37582774 Free PMC article.
QoL will be measured by the EuroQol 5-dimensional questionnaire (EQ-5D-5L). A health economic evaluation using health insurance data will measure cost-effectiveness. ...
QoL will be measured by the EuroQol 5-dimensional questionnaire (EQ-5D-5L). A health economic evaluation using health insurance data …
Health Status, Quality of Life, Psychosocial Well-being, and Wearables Data of Patients With Active Ulcerative Colitis Receiving Filgotinib Therapy (FilgoColitis Study): Protocol for a Real-world Observational Study.
Plachta-Danielzik S, Grasskemper L, Schmidt K, Schreiber S, Bokemeyer B. Plachta-Danielzik S, et al. JMIR Res Protoc. 2023 May 8;12:e42574. doi: 10.2196/42574. JMIR Res Protoc. 2023. PMID: 37155235 Free PMC article.
QoL is assessed with validated questionnaires: the Short Inflammatory Bowel Disease Questionnaire (sIBDQ) for the disease-specific QoL, the EQ-5D for the general QoL, and the fatigue questionnaire (Inflammatory Bowel Disease-Fatigue [IBD-F]). ...
QoL is assessed with validated questionnaires: the Short Inflammatory Bowel Disease Questionnaire (sIBDQ) for the disease-specific QoL, the …
121 results